Search results

Lithium Australia, a company that has a close association with ANSTO’s business unit Minerals, has been awarded a US patent for its unique lithium mining technology SiLeach®.

Our research group carries out fundamental research uniquely applied to industrial problems in the areas of uranium, rare earth and lithium processing.

ANSTO is pleased to welcome The Hon Dr Annabelle Bennett AO SC as the new ANSTO Board Chairperson, following the announcement from the Minister for Industry, Science and Technology. 

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.

Dr Linda Croton, a Research Fellow at Monash University, has been awarded the 2020 ANSTO Australian Synchrotron Stephen Wilkins Thesis medal for her outstanding work using synchrotron-based X-ray for brain imaging.

The final report on the safety of Building 23 by the independent expert review team has been completed.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

Voucher scheme accelerating medical research

Highlights of the Energy Materials Project.

Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.

Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.